Avience Biomedicals Ltd Share Price History
NSE : 25 Jun, 2026
414.950.0 (0.0%)
Prev Close
0.0
Open Price
395.2
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
0
Today's High / Low
415.0 / 395.2
52 WK High / Low
415.0 / 395.2
Market Price of Avience Biomedicals Ltd
1M
1Y
3Y
5Y
Monitoring Avience Biomedicals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2024 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 6.57 |
| YoY Gr. | - |
| Net Profit (Cr.) | 2 |
| BVPS | 18.96 |
Key Financial Parameters
| Parameter | 2024 |
|---|---|
| Return on Capital Emp. % | 18.41 |
| Op. Profit Mgn % | 19.16 |
| Net Profit Mgn % | 9.02 |
| Debt to Equity % | 2.43 |
Latest Shareholding
Promoters Holdings Over Time
About Avience Biomedicals Ltd
- Avience Biomedicals Limited was originally incorporated as Private Limited Company as 'Avience Biomedicals Private Limited' on December 23, 2019 with the Registrar of Companies, Delhi.
- Later, Company's status got converted into a Public Limited Company, the name of the Company was changed to 'Avience Biomedicals Limited' and fresh Certificate of Incorporation dated September 3, 2024, was issued by the Registrar of Companies, Delhi. Avience Biomedicals Limited is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India.
- In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections. The Company commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, Human Immunodeficiency Viruses (HIV), HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and good-quality solutions.
Popular Search
FAQs for null Share Price History
What are the key events that typically impact Avience Biomedicals Ltd's share price history?
Key events that impact Avience Biomedicals Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Avience Biomedicals Ltd's share price history?
Stock splits reduce the nominal price of Avience Biomedicals Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Avience Biomedicals Ltd?
Dividends can influence Avience Biomedicals Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Avience Biomedicals Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Avience Biomedicals Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Avience Biomedicals Ltd’s share price history?
To understand Avience Biomedicals Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
